Back
Range Cancer Therapeutics ETF Vs. Virtus LifeSci Biotech Products ETF Industry Stock Comparison
Buy
54
CNCR
Range Cancer Therapeutics ETF
Last Price:
14.00
Seasonality Move:
2.55%
Buy
74
BBP
Virtus LifeSci Biotech Products ETF
Last Price:
63.86
Seasonality Move:
5.11%
Buy
54
Range Cancer Therapeutics ETF (CNCR)
is a Buy
Is Range Cancer Therapeutics ETF a Buy, Sell or Hold?
- The current Range Cancer Therapeutics ETF [CNCR] share price is $14.19. The Score for CNCR is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
- CNCR is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
74
Virtus LifeSci Biotech Products ETF (BBP)
is a Buy
Is Virtus LifeSci Biotech Products ETF a Buy, Sell or Hold?
- The current Virtus LifeSci Biotech Products ETF [BBP] share price is $65.86. The Score for BBP is 74, which is 48% above its historic median score of 50, and infers lower risk than normal.
- BBP is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
CNCR Stock Price Chart
What is Range Cancer Therapeutics ETF's stock price today?
-
The Range Cancer Therapeutics ETF share price today is $14.19
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CNCR is experiencing buying pressure, which is a positive indicator for future bullish movement.
BBP Stock Price Chart
What is Virtus LifeSci Biotech Products ETF's stock price today?
-
The Virtus LifeSci Biotech Products ETF share price today is $65.86
The current trend is moderately bearish and BBP is experiencing buying pressure, which is a positive indicator for future bullish movement.
CNCR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.35 | Sell |
| Relative Strength Index (14 RSI): | 47.36 | Sell |
| Chaikin Money Flow: | 4099 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (13.71 - 15.35) | Sell |
| Bollinger Bands (100): | (14.11 - 15.45) | Sell |
BBP Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.08 | Buy |
| Relative Strength Index (14 RSI): | 58.28 | Buy |
| Chaikin Money Flow: | 994 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (62.38 - 66.44) | Buy |
| Bollinger Bands (100): | (61.31 - 64.81) | Buy |
CNCR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 13.6 | Buy |
| 20-day SMA: | 14.43 | Sell |
| 50-day SMA: | 14.76 | Sell |
| 200-day SMA: | 15.02 | Sell |
| 8-day EMA: | 13.87 | Buy |
| 20-day EMA: | 14.22 | Sell |
| 50-day EMA: | 14.57 | Sell |
| 200-day EMA: | 14.54 | Sell |
BBP Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 63.14 | Buy |
| 20-day SMA: | 64.51 | Buy |
| 50-day SMA: | 63.58 | Buy |
| 200-day SMA: | 59.89 | Buy |
| 8-day EMA: | 64.21 | Buy |
| 20-day EMA: | 64.08 | Buy |
| 50-day EMA: | 63.65 | Buy |
| 200-day EMA: | 60.37 | Buy |
Range Cancer Therapeutics ETF Earnings Growth & CNCR Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Virtus LifeSci Biotech Products ETF Earnings Growth & BBP Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Range Cancer Therapeutics ETF Technical Analysis
| Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | Nov 26 | Nov 27 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 14 | 15 | 18 | 19 | 20 | 21 | 22 | 25 | 26 | 27 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Virtus LifeSci Biotech Products ETF Technical Analysis
| Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | Nov 26 | Nov 27 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 14 | 15 | 18 | 19 | 20 | 21 | 22 | 25 | 26 | 27 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||